Diversified Trust Co Invests $203,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)


Share on StockTwits

Diversified Trust Co bought a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 5,088 shares of the pharmacy operator’s stock, valued at approximately $203,000.

Several other institutional investors have also bought and sold shares of the company. Rockland Trust Co. increased its holdings in shares of Walgreens Boots Alliance by 1.7% in the 4th quarter. Rockland Trust Co. now owns 14,490 shares of the pharmacy operator’s stock worth $578,000 after buying an additional 246 shares during the last quarter. Oarsman Capital Inc. increased its holdings in shares of Walgreens Boots Alliance by 1.3% in the 3rd quarter. Oarsman Capital Inc. now owns 19,119 shares of the pharmacy operator’s stock worth $687,000 after buying an additional 250 shares during the last quarter. LVW Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 0.5% in the 3rd quarter. LVW Advisors LLC now owns 55,005 shares of the pharmacy operator’s stock worth $1,976,000 after buying an additional 292 shares during the last quarter. Trust Co. of Toledo NA OH increased its holdings in shares of Walgreens Boots Alliance by 5.0% in the 3rd quarter. Trust Co. of Toledo NA OH now owns 6,198 shares of the pharmacy operator’s stock worth $223,000 after buying an additional 295 shares during the last quarter. Finally, Cardinal Capital Management increased its holdings in shares of Walgreens Boots Alliance by 0.7% in the 3rd quarter. Cardinal Capital Management now owns 43,067 shares of the pharmacy operator’s stock worth $1,547,000 after buying an additional 295 shares during the last quarter. Hedge funds and other institutional investors own 55.96% of the company’s stock.

NASDAQ:WBA opened at $48.94 on Thursday. Walgreens Boots Alliance, Inc. has a 52 week low of $33.36 and a 52 week high of $54.79. The firm has a 50 day moving average of $41.34 and a 200 day moving average of $39.34. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $42.29 billion, a price-to-earnings ratio of 97.88, a PEG ratio of 1.52 and a beta of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, January 6th. The pharmacy operator reported $1.22 EPS for the quarter, beating the Zacks’ consensus estimate of $1.03 by $0.19. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The company had revenue of $36.31 billion during the quarter, compared to analysts’ expectations of $35.01 billion. During the same quarter in the prior year, the company posted $1.37 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 4.84 EPS for the current year.

In related news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total transaction of $207,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 16.91% of the company’s stock.

WBA has been the topic of several analyst reports. Truist Financial upped their price target on shares of Walgreens Boots Alliance from $40.00 to $44.00 in a report on Tuesday, January 5th. ValuEngine upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Tuesday, December 1st. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $38.00 price objective for the company in a research report on Monday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Walgreens Boots Alliance from $41.00 to $44.00 and gave the company a “hold” rating in a research report on Friday, January 8th. Finally, Truist boosted their price objective on shares of Walgreens Boots Alliance from $44.00 to $48.00 in a research report on Friday, January 8th. Four investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $44.22.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Read More: What is a Roth IRA?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.